Form 4: NEXGEL CEO Adam Levy Sells 13,000 Shares
Statement of Changes in Beneficial Ownership
NEXGEL, Inc. CEO Adam R. Levy reported the sale of 13,000 shares of common stock in open market transactions.
Summary
- CEO Adam R. Levy sold a total of 13,000 shares of NEXGEL common stock between May 27 and May 29, 2026.
- The sales were executed in three separate transactions at weighted average prices ranging from approximately $0.5975 to $0.6058 per share.
- Following these transactions, the CEO retains beneficial ownership of 344,692 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale represents a minor reduction in the CEO's total position and is typical of standard executive equity management.
Positives
- The transactions represent a small portion of the CEO's total holdings, indicating continued significant alignment with shareholder interests.
Negatives
- Insider selling by a Chief Executive Officer can sometimes be perceived by the market as a lack of confidence in near-term share price appreciation.
Risks
- Market liquidity risks associated with trading small volumes of micro-cap stocks.
- Potential negative market sentiment resulting from executive divestment.
Future Outlook
No forward-looking guidance or strategic outlook was provided in this regulatory filing.
Management Comments
- The reporting person undertakes to provide full information regarding the number of shares sold at each separate price if requested by the SEC, the Issuer, or a security holder.
Industry Context
StockSavvy.ai notes that routine insider selling by executives is common and often related to tax obligations or personal financial planning rather than a reflection of company performance.
Comparison to Industry Standards
- Executive divestment of small blocks of shares is standard practice for officers in micro-cap companies and does not necessarily signal a change in corporate strategy.
Stakeholder Impact
- Minor impact on shareholder perception due to the relatively small volume of shares sold.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/27/2026 | Initial date of reported stock sales. |
| 05/28/2026 | Second date of reported stock sales. |
| 05/29/2026 | Final date of reported stock sales and filing date. |
Keywords
NEXGEL, NXGL, Insider Trading, Form 4, Adam Levy, Executive Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.